Viveve Medical Inc.

0.100000.00Vol 265.43K1Y Perf -90.29%
Feb 3rd, 2023 14:55 DELAYED
BID0.00 ASK0.00
Open0.1000 Previous Close0.1000
Pre-Market- After-Market-
 - -  - -%
Target Price
6.25 
Analyst Rating
— 0.00
Potential %
6.15K 
Finscreener Ranking
★★★★ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     28.07
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     26.83
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.78 
Earnings Rating
Neutral
Market Cap1.07M 
Earnings Date
16th Mar 2023
Alpha-0.11 Standard Deviation0.23
Beta0.60 

Today's Price Range

0.09950.1150

52W Range

0.09101.24

5 Year PE Ratio Range

-1.70-0.1000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-16.67%
1 Month
-84.00%
3 Months
-81.98%
6 Months
-86.15%
1 Year
-90.29%
3 Years
-99.04%
5 Years
-100.00%
10 Years
-

TickerPriceChg.Chg.%
VIVE0.10000.00000.00
AAPL154.503.68002.44
GOOG105.22-3.5800-3.29
MSFT258.35-6.2550-2.36
XOM111.920.77000.69
WFC47.580.35000.74
JNJ164.61-0.9300-0.56
FB196.640.99000.51
GE81.96-1.9800-2.36
JPM141.092.15001.55
 
ProfitabilityValueIndustryS&P 500US Markets
16.40
-311.00
-299.20
-381.20
-
RevenueValueIndustryS&P 500US Markets
5.12M
0.48
-21.33
-15.57
Earnings HistoryEstimateReportedSurprise %
Q03 2022--0.59-
Q02 2022--0.67-
Q01 2022--0.67-
Q04 2021--0.72-
Q03 2021--0.67-
Q02 2021--0.49-
Q01 2021--0.80-
Q03 2020--2.60-
Earnings Per EndEstimateRevision %Trend
9/2019 QR-16.004.02Positive
12/2019 QR-16.004.02Positive
12/2022 FY-2.553.04Positive
12/2023 FY-1.603.03Positive
Next Report Date16th Mar 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume265.43K
Shares Outstanding10.72K
Shares Float10.64M
Trades Count59
Dollar Volume28.18K
Avg. Volume409.34K
Avg. Weekly Volume132.81K
Avg. Monthly Volume779.38K
Avg. Quarterly Volume315.82K

Viveve Medical Inc. (NASDAQ: VIVE) stock closed at 0.1 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 265.43K shares and market capitalization of 1.07M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 55 people. Viveve Medical Inc. CEO is Scott C. Durbin.

The one-year performance of Viveve Medical Inc. stock is -90.29%, while year-to-date (YTD) performance is -76.47%. VIVE stock has a five-year performance of -100%. Its 52-week range is between 0.091 and 1.24, which gives VIVE stock a 52-week price range ratio of 0.78%

Viveve Medical Inc. currently has a PE ratio of -0.20, a price-to-book (PB) ratio of 5.98, a price-to-sale (PS) ratio of 1.43, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -132.28%, a ROC of -195.51% and a ROE of -261.13%. The company’s profit margin is -%, its EBITDA margin is -299.20%, and its revenue ttm is $5.12 Million , which makes it $0.48 revenue per share.

Of the last four earnings reports from Viveve Medical Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Viveve Medical Inc.’s next earnings report date is 16th Mar 2023.

The consensus rating of Wall Street analysts for Viveve Medical Inc. is (0), with a target price of $6.25, which is +6 150.00% compared to the current price. The earnings rating for Viveve Medical Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Viveve Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Viveve Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.63, ATR14 : 0.07, CCI20 : -55.91, Chaikin Money Flow : -0.14, MACD : -0.11, Money Flow Index : 2.31, ROC : -54.57, RSI : 31.95, STOCH (14,3) : 4.76, STOCH RSI : 0.00, UO : 25.94, Williams %R : -95.24), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Viveve Medical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0
0 (0.00 %)
0 (0.00 %)
Hold
0
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0
0 (0.00 %)
0 (0.00 %)
Strong Sell
0
0 (0.00 %)
0 (0.00 %)
Summary Rating-
0.00
Strong Buy
1.00
Strong Buy
1.00

Viveve Medical Inc.

Viveve Medical Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories. The Geneveve is indicated for use in general procedures for electrocoagulation and hemostasis in the US. The firm markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.

CEO: Scott C. Durbin

Telephone: +1 720 696-8100

Address: 345 Inverness Drive South, Englewood 80112, CO, US

Number of employees: 55

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

Bearish Bullish

55%45%


News

Stocktwits